LINDSEY MORRISON: Open Payments
NPI 1962831412 · KNIGHTSTOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,852 in 110 payments from 28 companies in 2025. Trend: 2023 $2,765 · 2024 $2,414 · 2025 $1,852
Food & beverage: $1,852
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $278 |
| Lundbeck LLC | 13 | $190 |
| Vanda Pharmaceuticals Inc. | 6 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $126 |
| Otsuka America Pharmaceutical, Inc. | 6 | $125 |
| Novo Nordisk Inc | 6 | $96 |
| Merck Sharp & Dohme LLC | 5 | $84 |
| Exact Sciences Corporation | 4 | $65 |
| PFIZER INC. | 4 | $64 |
| Lilly USA, LLC | 4 | $64 |
Products named: REXULTI, CAPLYTA, HETLIOZ, QULIPTA, Ozempic, JARDIANCE, VERQUVO, VRAYLAR.
Industry payments across IN — which companies pay providers there.
